M&A dealmaking in the contract research organization sector strikes again as PPD buys a company. Read how the Acurian acquisition helps Wilmington-based PPD.
November 30, 2012
PPD's 3D technology for global training in clinical trials receives the Best Technological Development in Clinical Trials honor from Scrip, an international life science media and technology firm.
November 21, 2012
Oxygen Biotherapeutics picks PPD as the contract research organization to run a Phase 2 clinical trial on a proposed treatment for traumatic brain injury.
October 25, 2012
Clinical research organization Clinipace's fundraising haul today of $9 million puts it in a position to do more of what the Morrisville company has been doing in over the last two years - finding and acquiring companies.
Clinipace's website touts its growing reach, expertise
September 17, 2012
Inside the Bulldog Blog: SAS wins XL Group as Visual Analytics customer; PPD to work with Europeans on allergies; ATTUS expands compliance services; DARA licenses topical gel; Chemring wins big defense contract.
Updated September 13, 2012
Lowe's, PPD, SAS, Bank of America and Martin Marietta also crack the top 200 in the annual ranking of information technology trend-setters as selected by InformationWeek magazine.
June 18, 2012
May 23, 2012
David Simmons will take over as the leader of the Wilmington-based life science services company on June 4. PPD has been without a CEO since December.
March 2, 2012
The study by Cary-based Industry Standard Research is possibly the most comprehensive measure of what pharmaceutical companies think about contract research organizations.
January 30, 2012
Pozen CEO says there are lessons to be learned from its past partnership deals as the Chapel Hill firm seeks another one.
Pozen CEO John Plachetka
January 12, 2012
"We expect growth in the CRO industry to continue accelerating into 2012 and the rise of the strategic partnership model should concentrate these benefits in the hands of a select group of narrow-moat providers," says a Morningstar analyst.
Updated December 26, 2011
Partners, M&A possibilities, sites in Asia, private equity investments and more consulting expertise are appealing items on the want lists for contract research organizations.
Updated December 14, 2011
PPD CEO Ray Hill has stepped down from the clinical research organization a week after PPD's acquisition by The Carlyle Group and Hellman & Friedman was finalized. He departs with a $3 million severance package for running the company since September.
December 5, 2011
The private equity firms announced the completion of the all-cash deal for the clinical research organization Monday. The close follows an approval vote from shareholders last week.
December 2, 2011
Even as shareholders approve the $3.9 billion sale of the contract research organization to private equity groups, the future role of PPD management remains unclear.
December 1, 2011
The Wilmington-based contract research organization is set to be taken over by The Carlyle Group and Hellman & Friedman.
November 30, 2011
The Wilmington-based contract research organization has scheduled a meeting for shareholders to vote whether to approve the sale to private equity firms The Carlyle Group and Hellman & Friedman. Online and telephone voting closed Tuesday night.
November 4, 2011
Scrips, an international life science media and related services firm based in the U.K., honors PPD with two awards, Novartis with three, and names Burrill its lifetime achievement winner.